Abstract
Aim:
To study the effects of carvedilol on the transmural heterogeneity of ventricular repolarization in rabbits with congestive heart failure (CHF).
Methods:
Rabbits were randomly divided into 3 groups: control, CHF and carvedilol treated CHF group. Monophasic action potential duration (MAPD) in the 3 myocardial layers was simultaneously recorded.
Results:
All the rabbits in the CHF group had signs of severe CHF. Compared with the control group, the mean blood pressure and cardiac output were significantly decreased, while peripheral resistance was significantly increased in the CHF group. This proved that the CHF model was successful created with adriamycin in this study. Compared to the control group, the ventricular fibrillation threshold (VFT) was remarkably decreased and all MAPD of the 3 myocardial layers were extended in rabbits with CHF. However, the extension of MAPD in the midmyocardium was more obvious. The transmural dispersion of repolarization (TDR) was significantly increased in CHF. Low-dose carvedilol (0.25 mg/kg, twice daily) had no effects on ventricular remodeling. Treatment with low-dose carvedilol significantly increased VFT. Although the MAPD of the 3 myocardial layers were further prolonged in the carvedilol treated CHF group, the prolongation of MAPD in the midmyocardium was shorter than those in the epicardium and endocardium. Treatment with low-dose carvedilol significantly decreased TDR in CHF.
Conclusion:
In the present study, the transmural heterogeneity of ventricular repolarization increased in the rabbits with CHF. Low-dose carvedilol decreased the transmural heterogeneity of ventricular repolarization in CHF, which may be related to its direct electrophysiological property rather than its effect on ventricular remodeling.
Similar content being viewed by others
Article PDF
References
Kjekshus J . Arrhythmias and mortality in congestive heart failure. Am J Cardiol 1990; 65: 421–81.
Bigger JT Jr . Why patients with congestive heart failure die: arrhythmias and sudden cardiac death. Circulation 1987; 75: IV28–35.
Antzelevitch C, Fish J . Electrical heterogeneity within the ventricular wall. Basic Res Cardiol 2001; 96: 517–27.
Drouin E, Charpentier F, Gauthier C, Laurent K, Le Marec H . Electrophysiologic characteristics of cells spanning the left ventricular wall of human heart: evidence for presence of M cells. J Am Coll Cardiol 1995; 26: 185–92.
Okazaki O, Wei D, Harumi K . A simulation study of Torsade de Pointes with M cells. J Electrocardiol 1998; 31 ( Suppl): 145–51.
Li Y, Xue Q, Ma J, Zhang CT, Qiu P, Wang L, et al. Effects of imidapril on heterogeneity of action potential and calcium current of ventricular myocytes in infarcted rabbits. Acta Pharmacol Sin 2004; 25: 1458–63.
Huang C, Bao M, Jiang H, Liu J, Yang B, Wang T . Differences in the changing trends of monophasic action potential duration and effective refractory period of the ventricular myocardium after myocardial infarction in vivo. Circ J 2004; 68: 1205–9.
Fowler MB . Carvedilol prospective randomized cumulative survival (COPERNICUS) trial: carvedilol in severe heart failure. Am J Cardiol 2004; 93: 35B–9B.
Kowey PR . A review of carvedilol arrhythmia data in clinical trials. J Cardiovasc Pharmacol Ther 2005; 10 ( Suppl 1): S59–68.
Bras-Silva C, Fontes-Sousa AP, Moura C, Areias JC, Leite-Moreira AF . Impaired response to ET (B) receptor stimulation in heart failure: functional evidence of endocardial endothelial dysfunction? Exp Biol Med (Maywood) 2006; 231: 893–8.
Kawai K, Qin F, Shite J, Mao W, Fukuoka S, Liang CS . Importance of antioxidant and antiapoptotic effects of beta-receptor blockers in heart failure therapy. Am J Physiol Heart Circ Physiol 2004; 287: H1003–12.
Korner PI, Oliver JR, Casley DJ . Effect of dietary salt on haemodynamics of established renal hypertension in the rabbit: Implications for the autoregulatory theory of hypertension. Hypertension 1980; 2: 794–801.
Ruan YF, Liu N, Zhou Q, Li Y, Wang L . Experimental study on the mechanism of sex difference in the risk of torsade de pointes. Chin Med J (Engl) 2004; 117: 538–41.
Zhang C, Li Y, Lu Z, Wu J, Wang C . Relationship between the U wave on electrocardiogram and the midmyocardium of the left ventricular wall. Chin Med J (Engl) 2002; 115: 509–12.
Wan YK, Holley L, Einstein R . Ventricular fibrillation and defibril-lation thresholds in sheep and dogs. Comp Biochem Physiol A Mol Integr Physiol 1998; 121: 77–82.
Qu L, Li F, Huang D . Effects of chronic heart failure on electrical remodeling of failing ventricles in rabbits. Chin J Card Pacing Electrophysiol 2000; 14: 75–8.
Yang Y, Tang Y, Ruan Y, Wang Y, Gao R, Chen J, et al. Comparison of metoprolol with low, middle and high doses of carvedilol in prevention of postinfarction left ventricular remodeling in rats. Jpn Heart J 2003; 44: 979–88.
Albert NM . Ventricular dysrhythmias in heart failure. J Cardiovasc Nurs 2004; 19 ( Suppl 6): S11–26.
Assomull RG, Prasad SK, Lyne J, Smith G, Burman ED, Khan M, et al. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol 2006; 48: 1977–85.
Anyukhovsky EP, Sosunov EA, Rosen MR . Regional differences in electrophysiological properties of epicardium, midmyocardium, and endocardium. In vitro and in vivo correlations. Circulation 1996; 94: 1981–8.
Sicouri S, Antzelevitch C . A subpopulation of cells with unique electrophysiological properties in the deep subepicardium of the canine ventricle. The M cell. Circ Res 1991; 68: 1729–41.
Akar FG, Spragg DD, Tunin RS, Kass DA, Tomaselli GF . Mechanisms underlying conduction slowing and arrhythmogenesis in nonischemic dilated cardiomyopathy. Circ Res 2004; 95: 717–25.
Sosunov EA, Anyukhovsky EP, Rosen MR . Effects of quinidine on repolarization in canine epicardium, midmyocardium, and endocardium: I. In vitro study. Circulation 1997; 96: 4011–8.
Sicouri S, Moro S, Elizari MV . D-sotalol induces marked action potential prolongation and early afterdepolarizations in M but not empirical or endocardial cells of the canine ventricle. J Cardiovasc Pharmacol Ther 1997; 2: 27–38.
Xie J, Dunn A, Tsikouris JP, Sun Y, Fan C, Kluger J, et al. A placebo controlled evaluation of the antifibrillatory effects of carvedilol. J Electrocardiol 2001; 34: 25–30.
Takusagawa M, Komori S, Matsumura K, Osada M, Kohno I, Umetani K, et al. The inhibitory effects of carvedilol against arrhythmias induced by coronary reperfusion in anesthetized rats. J Cardiovasc Pharmacol Ther 2000; 5: 105–12.
Keating GM, Jarvis B . Carvedilol: a review of its use in chronic heart failure. Drugs 2003; 63: 1697–741.
Author information
Authors and Affiliations
Corresponding author
Additional information
Project supported by the Research Foundation of the Education Bureau of Hainan province, China (No HJ200306).
Rights and permissions
About this article
Cite this article
Zhong, Jh., Chen, Xp., Yun, Ml. et al. Low-dose carvedilol reduces transmural heterogeneity of ventricular repolarization in congestive heart failure. Acta Pharmacol Sin 28, 1161–1165 (2007). https://doi.org/10.1111/j.1745-7254.2007.00613.x
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1111/j.1745-7254.2007.00613.x